Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2007

01-03-2007

Lymph Node Involvement in Locally Advanced Cervical Cancer Patients Administered Preoperative Chemoradiation versus Chemotherapy

Authors: Gabriella Ferrandina, MD, Mariagrazia Distefano, MD, Manuela Ludovisi, MD, Alessio Morganti, MD, Daniela Smaniotto, MD, Giuseppe D’Agostino, MD, Francesco Fanfani, MD, Giovanni Scambia, MD

Published in: Annals of Surgical Oncology | Issue 3/2007

Login to get access

Abstract

Background

A retrospective study was planned in 127 locally advanced cervical cancer (LACC) to investigate: (1) the rate and pattern of metastatic lymphnode involvement in patients administered preoperative chemoradiation (CT/RT) versus neoadjuvant chemotherapy (NACT), and (2) the profile of clinico-pathological parameters predictive of metastatic lymph node involvement in these two clinical settings. Finally, we investigated whether the pathologically assessed status of lower pelvic nodes (LPN) was able to predict the pathologically assessed status of upper pelvic nodes (UPN) and parametrium in cases administered CT/RT.

Methods

Patients were selected including LACC patients who were administered concomitant CT/RT (n = 87) or NACT (n = 40), before radical surgery.

Results

Metastatic pelvic lymphnode involvement was significantly lower in cases administered CT/RT (11.5%) compared to cases administered NACT (30.0%) (P value = 0.009). In the CT/RT group, only MRI-assessed pelvic node status (both at staging and post-treatment evaluation) was associated with pathologic pelvic node status. In patients administered CT/RT, the status of LPN appeared associated with the status of UPN.

Conclusions

(1) Preoperative CT/RT treatment is associated with a lower rate of pelvic node disease in LACC patients compared to NACT; (2) there is no association between the preoperative extent of residual cervical disease after CT/RT and pathologically assessed pelvic node status; (3) the pathological status of LPN is predictive of the pathological status of UPN and parametrium.
Literature
1.
go back to reference Goff B, Muntz HG, Paley PJ, Tamimi HK, et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999; 74:436–42PubMedCrossRef Goff B, Muntz HG, Paley PJ, Tamimi HK, et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999; 74:436–42PubMedCrossRef
2.
go back to reference Cosin JA, Fowler JM, Chen MD, Paley PJ, et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 1998; 82:2241–8PubMedCrossRef Cosin JA, Fowler JM, Chen MD, Paley PJ, et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 1998; 82:2241–8PubMedCrossRef
3.
go back to reference Benedetti Panici P, Cutillo G, Angioli R. Modulation of surgery in early invasive cervical cancer. Crit Rev Oncol/Hematol 2003; 48:263–270CrossRef Benedetti Panici P, Cutillo G, Angioli R. Modulation of surgery in early invasive cervical cancer. Crit Rev Oncol/Hematol 2003; 48:263–270CrossRef
4.
go back to reference Morice P, Castaigne D, Pautier P, et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999; 73:106–10PubMedCrossRef Morice P, Castaigne D, Pautier P, et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999; 73:106–10PubMedCrossRef
5.
go back to reference Berman ML, Keys H, Creasman W, et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic nodes (a Gynecologic Oncology group Study). Gynecol Oncol 1984; 19:8–16PubMedCrossRef Berman ML, Keys H, Creasman W, et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic nodes (a Gynecologic Oncology group Study). Gynecol Oncol 1984; 19:8–16PubMedCrossRef
6.
go back to reference Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database System Review 3: 2005 (CD002225) Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database System Review 3: 2005 (CD002225)
7.
go back to reference Benedetti Panici P, Greggi S, Scambia G, et al. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer 1998; 34(3):341–6PubMedCrossRef Benedetti Panici P, Greggi S, Scambia G, et al. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer 1998; 34(3):341–6PubMedCrossRef
8.
go back to reference Benedetti Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2001; 20:179–8CrossRef Benedetti Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2001; 20:179–8CrossRef
9.
go back to reference Jurado M, Martinez-Monge R, Garcia-Foncillas J, et al. A Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radiotherapy in locally advanced cervical cancer. Gynecol Oncol 1999; 74:30–7PubMedCrossRef Jurado M, Martinez-Monge R, Garcia-Foncillas J, et al. A Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radiotherapy in locally advanced cervical cancer. Gynecol Oncol 1999; 74:30–7PubMedCrossRef
10.
go back to reference Distefano M, Fagotti A, Ferrandina G, et al. Preoperative chemoradiotherapy in locally advanced cervical cancer: long term outcome and complications. Gynecol Oncol 2005; 1:S166–70 Distefano M, Fagotti A, Ferrandina G, et al. Preoperative chemoradiotherapy in locally advanced cervical cancer: long term outcome and complications. Gynecol Oncol 2005; 1:S166–70
11.
go back to reference Houvenaegel G, Lelievre L, Gonzague-Casabianca L, et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 2006; 100:338–43CrossRef Houvenaegel G, Lelievre L, Gonzague-Casabianca L, et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 2006; 100:338–43CrossRef
12.
go back to reference Benedetti Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996; 62:19–24PubMedCrossRef Benedetti Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996; 62:19–24PubMedCrossRef
13.
go back to reference Houvenaeghel G, Lelievre L, Rigouard AL, et al. Residual pelvic lymphnode involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol 2006;102(1):74–9PubMedCrossRef Houvenaeghel G, Lelievre L, Rigouard AL, et al. Residual pelvic lymphnode involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol 2006;102(1):74–9PubMedCrossRef
14.
go back to reference Benedetti Panici P, Angioli R, Palaia I, et al. Tailoring the parametrectomy in stages IA2-IB1 cervical carcinoma: is it feasible and safe? Gynecol Oncol 2005; 96:792–8CrossRef Benedetti Panici P, Angioli R, Palaia I, et al. Tailoring the parametrectomy in stages IA2-IB1 cervical carcinoma: is it feasible and safe? Gynecol Oncol 2005; 96:792–8CrossRef
15.
go back to reference Ferrandina G, Distefano M, Ludovisi M, et al. Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma. Gynecol Oncol 2005; 99(1):246–7PubMedCrossRef Ferrandina G, Distefano M, Ludovisi M, et al. Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma. Gynecol Oncol 2005; 99(1):246–7PubMedCrossRef
16.
go back to reference Scambia G, Ferrandina G, Distefano M, et al. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients? Gynecol Oncol 2001; 83:319–24PubMedCrossRef Scambia G, Ferrandina G, Distefano M, et al. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients? Gynecol Oncol 2001; 83:319–24PubMedCrossRef
17.
go back to reference Katz MH. Study design and statistical analysis: a practical guide for clinicians. Cambridge University press 2006, 27–28 Katz MH. Study design and statistical analysis: a practical guide for clinicians. Cambridge University press 2006, 27–28
18.
go back to reference D’Agostino G, Ferrandina G, Greggi S, et al. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel, and cisplatin. Cancer Chemother Pharmacol 2002; 49(3):256–60PubMedCrossRef D’Agostino G, Ferrandina G, Greggi S, et al. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel, and cisplatin. Cancer Chemother Pharmacol 2002; 49(3):256–60PubMedCrossRef
19.
go back to reference World Health Organization. WHO handbook of cancer treatment. WHO offset publication: Geneva 48:1979 World Health Organization. WHO handbook of cancer treatment. WHO offset publication: Geneva 48:1979
20.
go back to reference Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy. Obstet Gynecol 1974;44:265–72PubMed Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy. Obstet Gynecol 1974;44:265–72PubMed
21.
go back to reference Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990; 8:911–34PubMed Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990; 8:911–34PubMed
22.
go back to reference Lagasse LD, Smith ML, Moore JG, et al. The effect of radiation therapy on pelvic lymph node involvement in stage I carcinoma of the cervix. Am J Obstet Gynecol 1974; 119(3):328–34PubMed Lagasse LD, Smith ML, Moore JG, et al. The effect of radiation therapy on pelvic lymph node involvement in stage I carcinoma of the cervix. Am J Obstet Gynecol 1974; 119(3):328–34PubMed
23.
go back to reference Schneider A, Hertel H. Surgical and radiographic staging in patients with cervical cancer. Curr Opin Obstet Gynecol 2004; 16:11–8PubMedCrossRef Schneider A, Hertel H. Surgical and radiographic staging in patients with cervical cancer. Curr Opin Obstet Gynecol 2004; 16:11–8PubMedCrossRef
Metadata
Title
Lymph Node Involvement in Locally Advanced Cervical Cancer Patients Administered Preoperative Chemoradiation versus Chemotherapy
Authors
Gabriella Ferrandina, MD
Mariagrazia Distefano, MD
Manuela Ludovisi, MD
Alessio Morganti, MD
Daniela Smaniotto, MD
Giuseppe D’Agostino, MD
Francesco Fanfani, MD
Giovanni Scambia, MD
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9252-0

Other articles of this Issue 3/2007

Annals of Surgical Oncology 3/2007 Go to the issue